Notice of Intent to Sole Source- AL Genome Medical Company

Agency: DEPT OF DEFENSE
State: Federal
Type of Government: Federal
FSC Category:
  • 65 - Medical, Dental, and Veterinary Equipment and Supplies
  • Q - Medical Services
NAICS Category:
  • 621511 - Medical Laboratories
Posted Date: Sep 16, 2025
Due Date:
Solicitation No: N6817125Q0082
Original Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page

Description

Follow
Notice of Intent to Sole Source- AL Genome Medical Company
Active
Contract Opportunity
Notice ID
N6817125Q0082
Related Notice
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEPT OF THE NAVY
Major Command
NAVSUP
Sub Command
NAVSUP GLOBAL LOGISTICS SUPPORT
Sub Command 2
NAVSUP FLC SIGONELLA
Office
NAVSUP FLC SIGONELLA NAPLES OFFICE
General Information
  • Contract Opportunity Type: Special Notice (Original)
  • Original Published Date: Sep 16, 2025 10:48 am EDT
  • Original Response Date:
  • Inactive Policy: Manual
  • Original Inactive Date: Sep 23, 2025
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code:
  • NAICS Code:
    • 621511 - Medical Laboratories
  • Place of Performance:
Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
This procurement is for MERS ELISA kits. Part of NAMRU EURAFCENT (NAMRU-EAC) achieving its mission is establishing and conducting seroprevalence surveillance study on Middle East Respiratory Syndrome Coronaviruss in Jordan. Since the first outbreak of MERS-CoV that was reported in the Kingdom of Jordan, it has been important to continue monitoring the prevalence of MERS-CoV infections especially at the camel markets and closely monitor the camel traders and handlers to understand the epidemiology and risk factors that might lead to transmission from camels to human.
It is also important to determine active cases either symptomatic or asymptomatic with reference to their contact with camels or camel products.
Market research showed that not many companies manufacture camel MERS ELISA kits in general so the options were limited. Regarding human MERS IgM ELISA kit, other kits were overviewed as options with RayBiotech’s kit leading as a potential one, but validation of the kit was still being done, so the performance of the kit could not be predicted. That, alongside lower sensitivity and specificity values from other kits manufacturers led to choosing Abbexa kits. AL- Genome Medical Company is the manufacturer and sole vendor for instruments of these kinds of test kits.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 -Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.
Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to NAVSUP FLCI, prior to the closing date specified in this announcement, to the attention of Terry Herbert, Contract Specialist via email to by close date.
Attachments/Links
Contact Information
Contracting Office Address
  • NAVAL REGIONAL CONTRACTING CEN DET PSC 817 BOX 50
  • FPO , AE 09622-0050
  • USA
Primary Point of Contact
Secondary Point of Contact


History
  • Sep 16, 2025 10:48 am EDTSpecial Notice (Original)
Get Government Bids Like This by Email Receive daily bid alerts that match your keywords, business categories, and target regions.

See Also

Follow Dapagliflozin Tablets Active Contract Opportunity Notice ID SPE2D2-26-R-0018 Related Notice Department/Ind. Agency

DEPT OF DEFENSE

Follow Progesterone Capsules Active Contract Opportunity Notice ID SPE2D2-26-R-0015 Related Notice SPE2D2-26-R-0015 Department/Ind.

DEPT OF DEFENSE

Due by 9/18/2026

Follow 65--SURVIVAL KIT,INDIVIDUA Active Contract Opportunity Notice ID SPE2DS26T414R Related Notice Department/Ind. Agency

DEPT OF DEFENSE

Due by 9/15/2026

Follow 6505--Ticagrelor Tablets Active Contract Opportunity Notice ID 36E79726R0028 Related Notice 36E79726R0028 Department/Ind.

VETERANS AFFAIRS, DEPARTMENT OF

Due by 9/17/2026

* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.